Drug Type Small molecule drug |
Synonyms NG 012 |
Target |
Action stimulants |
Mechanism NGF stimulants(Nerve growth factor stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H38O15 |
InChIKeyQFILNQIVBJLREP-RZOYPLJHSA-N |
CAS Registry141731-76-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognition Disorders | Preclinical | Japan | - |